SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

H.C. Wainwright Maintains Buy on Jounce Therapeutics, Lowers Price Target to $8

H.C. Wainwright maintains Jounce Therapeutics (NASDAQ:JNCE) with a Buy and lowers the price target from $10 to $8.

Benzinga · 05/07/2020 12:48

H.C. Wainwright maintains Jounce Therapeutics (NASDAQ:JNCE) with a Buy and lowers the price target from $10 to $8.